Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Cady

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Headache|February 26, 2013
Sublingual feverfew/ginger (LipiGesic M) reanalysis of dataRoger Cady, Daniel Serrano, Richard Lipton, et al.
Headache|April 2, 2008
Nurse-based education: an office-based comparative model for education of migraine patientsRoger Cady, Kathleen Farmer, M E Beach, et al.
Headache|October 24, 2014
A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with tx360(®) as acute treatment for chronic migraineRoger Cady, Joel Saper, Kent Dexter, et al.
Pain Management|June 26, 2023
Treatment with eptinezumab for migraine prevention in people with chronic migraine and medication-overuse headache: a plain language summaryAmaal J Starling, Melissa Kolbet, Roger Cady, et al.
Current Pain and Headache Reports|December 31, 2004
Cosensitization of pain and psychiatric comorbidity in chronic daily headacheRoger Cady, Kathleen Farmer, J Kent Dexter, et al.
Acta Neurologica Scandinavica|February 26, 2022
Eptinezumab for migraine prevention in patients 50 years or olderVincent Martin, Cristina Tassorelli, Anders Ettrup, et al.
BMC Neurology|July 8, 2022
Long-term reductions in disease impact in patients with chronic migraine following preventive treatment with eptinezumabAndrew Blumenfeld, Anders Ettrup, Joe Hirman, et al.
Cephalalgia : an International Journal of Headache|March 18, 2022
Efficacy and safety of eptinezumab in patients with migraine and self-reported aura: Post hoc analysis of PROMISE-1 and PROMISE-2Messoud Ashina, Peter McAllister, Roger Cady, et al.
Cephalalgia : an International Journal of Headache|March 25, 2022
Reduction in migraine-associated burden after eptinezumab treatment in patients with chronic migrainePeter McAllister, David Kudrow, Roger Cady, et al.
Journal of Pharmacy Practice|August 13, 2014
Symptomatic Overlap and Therapeutic Opportunities in Primary HeadacheRoger Cady, Sandy Yacoub Garas, Ketu Patel, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Headache|February 26, 2013
Sublingual feverfew/ginger (LipiGesic M) reanalysis of dataRoger Cady, Daniel Serrano, Richard Lipton, et al.
Headache|April 2, 2008
Nurse-based education: an office-based comparative model for education of migraine patientsRoger Cady, Kathleen Farmer, M E Beach, et al.
Headache|October 24, 2014
A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with tx360(®) as acute treatment for chronic migraineRoger Cady, Joel Saper, Kent Dexter, et al.
Pain Management|June 26, 2023
Treatment with eptinezumab for migraine prevention in people with chronic migraine and medication-overuse headache: a plain language summaryAmaal J Starling, Melissa Kolbet, Roger Cady, et al.
Current Pain and Headache Reports|December 31, 2004
Cosensitization of pain and psychiatric comorbidity in chronic daily headacheRoger Cady, Kathleen Farmer, J Kent Dexter, et al.
Acta Neurologica Scandinavica|February 26, 2022
Eptinezumab for migraine prevention in patients 50 years or olderVincent Martin, Cristina Tassorelli, Anders Ettrup, et al.
BMC Neurology|July 8, 2022
Long-term reductions in disease impact in patients with chronic migraine following preventive treatment with eptinezumabAndrew Blumenfeld, Anders Ettrup, Joe Hirman, et al.
Cephalalgia : an International Journal of Headache|March 18, 2022
Efficacy and safety of eptinezumab in patients with migraine and self-reported aura: Post hoc analysis of PROMISE-1 and PROMISE-2Messoud Ashina, Peter McAllister, Roger Cady, et al.
Cephalalgia : an International Journal of Headache|March 25, 2022
Reduction in migraine-associated burden after eptinezumab treatment in patients with chronic migrainePeter McAllister, David Kudrow, Roger Cady, et al.
Journal of Pharmacy Practice|August 13, 2014
Symptomatic Overlap and Therapeutic Opportunities in Primary HeadacheRoger Cady, Sandy Yacoub Garas, Ketu Patel, et al.
Pageof 10